Evidence map›Paper›PMID 36499252›Full record

ArticleInternational journal of molecular sciences2022

Dual (pH- and ROS-) Responsive Antibacterial MXene-Based Nanocarrier for Drug Delivery.

Wei-Jin Zhang, Shuwei Li, Yong-Zhu Yan, Sung Soo Park, Anandhu Mohan, Ildoo Chung, Suk-Kyun Ahn, Jung Rae Kim, Chang-Sik Ha

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 29 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Research Progress on TiMolecules (Basel, Switzerland) · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Wei-Jin ZhangDepartment of Polymer Science and Engineering, School of Chemical Engineering, Pusan National University, Busan 46241, Republic of Korea.
Shuwei LiSchool of Chemical Engineering, Pusan National University, Busan 46241, Republic of Korea.
Yong-Zhu YanDepartment of Polymer Science and Engineering, School of Chemical Engineering, Pusan National University, Busan 46241, Republic of Korea.
Sung Soo ParkDivision of Advanced Materials Engineering, Dong-Eui University, Busan 47340, Republic of Korea.
Anandhu MohanDepartment of Industrial and Environmental Engineering, Gachon University, Seongnam 13120, Republic of Korea.
Ildoo ChungDepartment of Polymer Science and Engineering, School of Chemical Engineering, Pusan National University, Busan 46241, Republic of Korea.ORCID 0000-0001-9226-9151
Suk-Kyun AhnDepartment of Polymer Science and Engineering, School of Chemical Engineering, Pusan National University, Busan 46241, Republic of Korea.
Jung Rae KimSchool of Chemical Engineering, Pusan National University, Busan 46241, Republic of Korea.ORCID 0000-0003-0103-7457
Chang-Sik HaDepartment of Polymer Science and Engineering, School of Chemical Engineering, Pusan National University, Busan 46241, Republic of Korea.ORCID 0000-0003-4597-918X
Pusan National University · KRDong-Eui University · KRGachon University · KR

Funding

Korea Institute for Advancement of Technology P0017531National Research Foundation of Korea 2021R1I1A3060098, NRF-2021R1I1A3059777, and Brain Korea 21 Plus Program (4199990414196)
6 · The paper itself

Abstract

In this study, a novel MXene (Ti

Indexed as

Drug Delivery SystemsEscherichia coliAnti-Bacterial AgentsDoxorubicinDrug LiberationHydrogen-Ion ConcentrationNitritesSpectroscopy, Fourier Transform InfraredTransition ElementsAnti-Bacterial AgentsDoxorubicinMXeneNitritesTransition Elementsantibacterial activitydoxorubicindrug deliveryMXenepH-responsiveROS-responsive

Identifiers

PMID36499252
PMCPMC9739462
OpenAlexW4311041182

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.